Abstract:Background Methylmalonic aciduria (MMA), a rare inherited disorder, is the most common organic aciduria in China, and prenatal diagnosis has contributed to its prevention. However, the prenatal diagnosis of MMA using cultured amniocytes or chorionic villi to detect gene mutations is exclusively applicable to families with a definite genetic diagnosis. To evaluate the reliability of mass spectrometry assays for the prenatal diagnosis of MMA, we conducted a retrospective study of our 10 years’ experience. Materials and methods This retrospective compare study reviewed the medical records for maternal and fetuses data for 287 mothers with a family history of MMA from June 2010 to December 2020. Methylmalonate and propionylcarnitine in cell-free amniotic fluid were measured using a stable isotope dilution method (GC/MS) and MS/MS-based method (LC/MS/MS). Total homocysteine (tHcy) was measured by fluorescence polarization immunoassay. Depending on the presence of disease-causing gene mutations in probands, gene studies on amniocytes from 222 pregnant women were performed. Results For 222 fetuses of the families with definite genetic diagnosis, gene analyses were performed using cultured amniocytes. 52 fetuses were affected by MMA, whereas 170 were “unaffected”. For GC/MS and LC/MS/MS, the specificity was 96.5% and 95.9%, sensitivity was 71.2% and 84.6%, respectively. The positive and negative predictive values were 86.0% and 91.6% and 86.3% and 95.3%, respectively. Propionylcarnitine/butyrylcarnitine ratio showed the highest accuracy and could thus serve as a sensitive indicator to identify those at a risk for MMA. When GC/MS and LC/MS/MS were performed in parallel, the specificity was 92.5% and sensitivity was 95.6%. When evaluating tHcy, the positive and negative predictive values were 95.0% and 96.1%, respectively. In 65 fetuses without family genetic diagnosis, 11 were finally confirmed to have MMA and 54 were “unaffected” by amniotic fluid biochemical assays. The 54 children showed normal urine organic acids and healthy development after birth. Conclusions Amniotic fluid biochemical assays using GC/MS and LC/MS/MS in parallel increased the accuracy of prenatal diagnosis of MMA. Propionylcarnitine is a more reliable marker than methylmalonic acid in amniotic fluid. Further, tHcy is recommended for the prenatal diagnosis of combined MMA and homocysteinemia.

Improving methylmalonic acidemia (MMA) screening and MMA genotype prediction using random forest classifier in two Chinese populations

Phenotypic and genotypic analysis of children with methylmalonic academia: A single-center study in China and a recent literature review

[Screening for Newborn Organic Aciduria in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Improving the second-tier classification of methylmalonic acidemia patients using a machine learning ensemble method

Multi-disciplinary interventions for the management and prevention of methylmalonic academia

Clinical and genetic analysis of methylmalonic aciduria in 60 patients from Southern China: a single center retrospective study

Prenatal diagnosis of methylmalonic aciduria from amniotic fluid using genetic and biochemical approaches.

Comparing amniotic fluid mass spectrometry assays and amniocyte gene analyses for the prenatal diagnosis of methylmalonic aciduria

Biochemical, Molecular and Outcome Analysis of Eight Chinese Asymptomatic Individuals with Methyl Malonic Acidemia Detected Through Newborn Screening

A Multicenter Prospective Study of Next-Generation Sequencing-Based Newborn Screening for Monogenic Genetic Diseases in China

The follow-up of Chinese patients in mut-type methylmalonic acidemia identified through expanded newborn screening

Evaluation of the Clinical, Biochemical, Genotype and Prognosis Ofmut-Type Methylmalonic Acidemia in 365 Chinese Cases

A Study on a Cohort of 301 Chinese Patients with Isolated Methylmalonic Acidemia

Newborn Screening for Methylmalonic Aciduria by Tandem Mass Spectrometry: 7 Years' Experience from Two Centers in Taiwan.

Methylmalonic acidemia: Neurodevelopment and neuroimaging

Long-term follow-up of Chinese patients with methylmalonic acidemia of the cblC and mut subtypes

Evaluation of the clinical, biochemical, genotype and prognosis of mut-type methylmalonic acidemia in 365 Chinese cases

Mutation spectrum and genotype-phenotype correlation of pediatric patients with methylmalonic acidemia

Involvement of Protein Phosphatases in Gonadotropin Releasing Hormone Regulated Gonadotropin Secretion

Efficient Mass Spectrometric Characterization and Classification of Methylmalonic Aciduria Subtypes Through Urinary and Blood Metabolic Profiles Fusion

[Research progress on the prognosis of patients with various types of Methylmalonic acidemia].